Table 1.
Exon 1 | Exon 2 | |||||||
---|---|---|---|---|---|---|---|---|
Nucleotide position | c.159C>T | c.280C>T | c.281T>C | c.419C>T | c.504C>T | c.1021G>A | c.1156C>T | c.1857C>T |
Reference sequence | GCC.GCC.GAC | CTC.CTT.GAG | CTC.CTT.GAG | GGG.GCG.GCT | ACC.CGC.GCC | GAT.GCG.CCT | AAC.CTC.ATG | GGG.AGC.TTG |
Observed variation | GCC.GCT.GAC | CTC.TTT.GAG | CTC.CCT.GAG | GGG.GTG.GCT | ACC.CGT.GCC | GAT.ACG.CCT | AAC.TTC.ATG | GGG.AGT.TTG |
Coding impact | SILENT | p.Leu94Phe | SILENT | p.Ala140Val | SILENT | p.Ala341Thr | p.Leu386Phe | SILENT |
Incidence in disease cases | 25% (3/302)* | 1/302 | 1/302 | 9% (4%) | 3/302 | 2/302 (1/302) | 1/302 (1/302) | 4/302 |
Incidence in controls | 18% | 0% | 0% | 27% | 0% | 0% | 0% | 0% |
SNP databases | Y (rs11757217) | N | N | N | N | N | N | N |
Causal? | No | ? | No | No | No | ? | ? | No |